Formula: | C18H29FN4O4S2 |
Molecular Weight: | 448.59 |
Rotatable Bond Donors: | 8 |
clogP: | 0.79 |
Topological Polar Surface Area: | 81.24 |
Lipinski's RO5: | MW: 448.59 HBA: 8 HBD: 0 RB: 8 LogP: 0.79 |
Rule of Three: | MW: 448.59 HBA: 8 HBD: 0 RB: 8 LogP: 0.79 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS33197 | 0.84 | EOS33197 RDKit 3D 29 31 0 0 0 0 0 0 0 0999 V2000 -1.1702 -4.1746 -1.9725 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5214 -3.0800 -2.8850 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.8300 -3.6487 -4.2070 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7577 -2.0682 -2.3276 S 0 0 0 0 0 0 0 0 0 0 0 0 -3.7018 -2.8755 -1.5907 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.1697 -1.2335 -3.4338 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.9156 -1.1067 -1.2570 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.8878 -0.2373 -1.8493 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4820 1.1171 -2.1968 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5382 2.0174 -1.0437 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.8113 2.7304 -1.1564 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5517 4.1345 -0.6187 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0432 4.2737 -0.5772 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.5016 3.0268 -1.2506 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6187 -1.6441 0.0712 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8483 -0.5923 1.1290 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4782 0.0141 1.3501 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4821 -1.0938 1.1325 N 0 0 0 0 0 0 0 0 0 0 0 0 1.9865 -0.6105 0.5118 S 0 0 0 0 0 0 0 0 0 0 0 0 1.7462 0.2836 -0.6014 O 0 0 0 0 0 0 0 0 0 0 0 0 2.7981 -1.7963 0.3446 O 0 0 0 0 0 0 0 0 0 0 0 0 2.6647 0.3165 1.8410 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6539 1.7079 1.7802 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2439 2.4326 2.8115 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8489 1.7533 3.8683 C 0 0 0 0 0 0 0 0 0 0 0 0 4.4403 2.4522 4.8478 F 0 0 0 0 0 0 0 0 0 0 0 0 3.8682 0.3609 3.9182 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2742 -0.3657 2.8909 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1794 -2.0939 0.2555 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 2 4 1 0 4 5 2 0 4 6 2 0 4 7 1 0 7 8 1 0 8 9 1 0 9 10 1 0 10 11 1 0 11 12 1 0 12 13 1 0 13 14 1 0 7 15 1 0 15 16 1 0 16 17 1 0 17 18 1 0 18 19 1 0 19 20 2 0 19 21 2 0 19 22 1 0 22 23 2 0 23 24 1 0 24 25 2 0 25 26 1 0 25 27 1 0 27 28 2 0 18 29 1 0 14 10 1 0 29 15 1 0 28 22 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |